Tcwp LLC purchased a new position in shares of Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) in the 1st quarter, HoldingsChannel.com reports. The institutional investor purchased 390 shares of the biopharmaceutical company’s stock, valued at approximately $41,000. Several other hedge funds have also recently added to or reduced their stakes in HZNP. Nuveen Asset […]
Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) EVP Andy Pasternak sold 762 shares of the company’s stock in a transaction dated Friday, June 10th. The stock was sold at an average price of $85.36, for a total transaction of $65,044.32. Following the completion of the sale, the executive vice president now directly owns 38,897 […]
Stock analysts at UBS Group assumed coverage on shares of Horizon Therapeutics Public (NASDAQ:HZNP – Get Rating) in a report issued on Monday, The Fly reports. The brokerage set a “buy” rating on the biopharmaceutical company’s stock. Several other equities research analysts have also commented on the stock. Wells Fargo & Company restated a “buy” […]
Equities analysts expect that Horizon Therapeutics Public Limited (NASDAQ:HZNP – Get Rating) will announce $936.44 million in sales for the current fiscal quarter, Zacks reports. Six analysts have provided estimates for Horizon Therapeutics Public’s earnings. The lowest sales estimate is $925.60 million and the highest is $949.60 million. Horizon Therapeutics Public reported sales of $832.55 […]